In clear cell Renal Cell Carcinoma (ccRCC), Y-box binding protein 1 (YB1) mediated upregulation of EphA2 by reducing its proteasomal degradation and this strongly correlated with resistance to sunitinib and acquisition of invasive properties. This evidence concerns the gene YBX1 and clear cell renal carcinoma.